Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in Chronic Kidney Disease: Who, When, and How? A Position Statement by Nephrologists

By sjmartinez • August 15, 2024

Rastogi A, Collins A, Kelepouris E, Kotzker W, Middleton JP, Rajpal M, Roy-Chaudhury P, Chertow GM. Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in Chronic Kidney Disease: Who, When, and How? A Position Statement by Nephrologists. J Prim Care Community Health. 2024 Jan-Dec;15:21501319241259905. doi: 10.1177/21501319241259905. PMID: 39143759.

Tags: Chronic kidney disease, consensus, KDIGO, Nephrology, Publications, SGLT2 inhibitor, treatment algorithm

Discovery of Endothelial Cell Antibodies Associated with Pediatric and Adult Kidney Allograft Rejection and Assessment of a non-HLA Antibody Assay

Butler CL, Hickey MJ, Pearl MH, Zheng Y, Gjertson D, Sunga G, Chen L, Vangala S, Elashoff D, Weng P, Lum E, Bunnapradist S, Abdalla[...]

How We Plan Preconception in Systemic Lupus Erythematosus and Manage Lupus Nephritis in Pregnancy

Dukkipati R, Shah A, Desai S. How We Plan Preconception in Systemic Lupus Erythematosus and Manage Lupus Nephritis in Pregnancy. Clin J Am Soc Nephrol.[...]

Nondialytic Care vs Dialysis Transition on Hospitalization: Outcomes in Veterans With Advanced Chronic Kidney Disease

Rhee CM, Narasaki Y, Crowley ST, Kovesdy CP, Mukamel DB, You AS, Nguyen M, Siu MKM, Le L, Novoa A, Nguyen DV, Kalantar-Zadeh K. Nondialytic[...]